Cargando…
Second Complete Remission of Relapsed Stage IV Non-Small Cell Lung Cancer Following Retreatment
Non-small cell lung cancer (NSCLC) is the leading cause of cancer related deaths. Most patients were presented with advanced disease at the time of diagnosis. In advanced NSCLC, it is almost impossible to anticipate complete remission by using only cytotoxic chemotherapy or molecularly targeted agen...
Autores principales: | Yoo, Su Jin, Lee, Jeong Eun, Jung, Sun Young, Park, Dong Il, Park, Myoung Rin, Park, Hee Sun, Jung, Sung Soo, Kim, Ju Ock, Kim, Sun Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510290/ https://www.ncbi.nlm.nih.gov/pubmed/23227080 http://dx.doi.org/10.4046/trd.2012.72.4.381 |
Ejemplares similares
-
Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission
por: Lee, Je-Hwan, et al.
Publicado: (2010) -
Progression-Free Survival: An Important Prognostic Marker for Long-Term Survival of Small Cell Lung Cancer
por: Park, Myoung-Rin, et al.
Publicado: (2014) -
Lesser Toxicities of Belotecan in Patients with Small Cell Lung Cancer: A Retrospective Single-Center Study of Camptothecin Analogs
por: Park, Yeon Hee, et al.
Publicado: (2016) -
Incidence and clinical predictors of endobronchial tuberculosis in patients with pulmonary tuberculosis
por: Jung, Sung-Soo, et al.
Publicado: (2015) -
Retreatment of Patients With Metastatic Cutaneous Melanoma Who Relapse After Elective Checkpoint Inhibitor Discontinuation After a Complete Remission
por: Sadrolashrafi, Kaviyon, et al.
Publicado: (2023)